There may possibly be a new drug that will be FDA approved to treat Fibromyalgia. Karen Lee Richards from Chronic Pain Connectionwrites that she has been watching the drug Milnaciprin over the years as it has made its way through numerous clinical trials on its way to being FDA approved.
Milnaciprin is a serotonin and norepinephrine reuptake inhibitor (SNRI). It is not approved yet in the United States to treat any illness, but it is used in other countries to treat depression. Karen writes:
Milnaciprin was developed by Cypress Bioscience and licensed to Forest Laboratories in the U.S. and Canada. Late in 2007 Forest and Cypress filed an application for FDA approval of milnaciprin for the treatment of fibromyalgia. Predictions are that it has a 70 80 percent chance of being approved within the next month or two. The worst-case scenario is that it might take up to nine months to get approval.
Currently Lyrica and Cymbalta are the only two drugs FDA approved for the treatment of Fibromyalgia. If milnaciprin is approved, doctors and physicians will have yet another medication to offer their FM patients. I am happy that there has been so much progress in the treatment of Fibromyalgia and that the illness is finally being taken seriously. Now if we could just get the same results for ME/CFS. I would be ecstatic!
CHRISTINE KIDD PATTERSON says
this sounds wonderful i have had fibro and chronic fatigue for 4 years now and have been taking lyrica and cymbalta and also topamax for migraines as well . is there very n=many if any side effects like with lyrica has? what is there difference than what lyria and cymabalta does? i am so excited to see of this new drugs works better please get back to me —christine in ky